Human mutations that truncate the massive sarcomere protein titin [TTN-truncating variants (TTNtvs)] are the most common genetic cause for dilated cardiomyopathy (DCM), a major cause of heart failure and premature death. Here we show that cardiac microtissues engineered from human induced pluripotent stem (iPS) cells are a powerful system for evaluating the pathogenicity of titin gene variants. We found that certain missense mutations, like TTNtvs, diminish contractile performance and are pathogenic. By combining functional analyses with RNA sequencing, we explain why truncations in the A-band domain of TTN cause DCM, whereas truncations in the I band are better tolerated. Finally, we demonstrate that mutant titin protein in iPS cell-derived cardiomyocytes results in sarcomere insufficiency, impaired responses to mechanical and b-adrenergic stress, and attenuated growth factor and cell signaling activation. Our findings indicate that titin mutations cause DCM by disrupting critical linkages between sarcomerogenesis and adaptive remodeling.
D
ilated cardiomyopathy (DCM) is characterized by progressive left ventricular dilation; systolic dysfunction; and, ultimately, heart failure. Occurring in 1 of 250 adults (1), DCM arises from underlying cardiovascular conditions or as a primary genetic disorder. We recently identified dominant mutations that truncate the sarcomere protein titin [TTNtruncating variants (TTNtvs)] as the most common genetic cause of DCM, occurring in~20% of familial or sporadic cases (2) .
TTN is a massive protein that spans half of the sarcomere (1 mm) and includes >34,000 amino acids within four functionally distinct segments ( Fig. 1A) : (i) an N-terminus that is anchored at the Z disk; (ii) a distensible I band (~1 MD) composed of repeating immunoglobulin-like domains and disordered regions; (iii) an inextensible, thick filament-binding A band (~2 MD); and (iv) a carboxyl M band with a kinase domain. TTNtvs have been identified in each protein segment, but TTNtvs in DCM patients are markedly enriched in the A band (2, 3) . In addition, numerous rare missense variants in TTN have been identified, most with unknown medical importance (2, 3) . Both TTN's size and a general incomplete knowledge of the protein's function in cardiomyocyte biology have hindered traditional approaches for elucidating why some TTN mutations produce clinical phenotypes. To address this, we harnessed recent advances in stem cell reprogramming (4), gene editing (5) , and tissue engineering (6) to produce human cardiac microtissue (CMT) models of TTNtvs.
We generated human induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) from patients (labeled with "p" preceding genotype) (see supplementary materials and methods). Cryopreserved blood samples from one unaffected and three DCM patients with dominant TTN mutations ( Fig. 1A and table S1A) were reprogrammed, and high-quality iPS cell clones (fig. S1, A to C) were expanded, differentiated (7) , and enriched by metabolic selection (8) to achieve cultures with >90% iPS-CMs ( fig. S2 , A to C). We produced iPS-CMs with two A-band TTNtvs (pA22352fs +/− or pP22582fs +/− ) and a missense mutation (pW976R +/− ) within the Z/I junction that cosegregated with DCM in a large family (9) . Single-cell assays of contractile function on microarray post detectors (mPADS) (10) showed no significant difference between wild-type (WT) and TTNtv iPS-CMs ( fig. S2D ). Because threedimensional (3D) CMTs (Fig. 1B) better recapitulate native cardiomyocyte architecture and mechanics, improving sarcomere alignment, expression of contractile proteins, and iPS-CMs maturity (6, 11, 12) , we assessed the contractile function of iPS-CMTs containing WT or mutant iPS-CMs. We observed minor variation in contractile function between biological replicates of CMTs or between CMTs made from independent clones from the same patient ( fig. S2, E and F) . However, CMTs expressing either A-band TTNtv or W976R +/− variants exhibited less than half the contractile force (Fig. 1, C and D, and movies S1 to S6) or the stress (force normalized to tissue area) ( fig. S2I ) generated by pWTs, and function did not improve over time ( fig. S2G ). As static force was similar in pWT and pP22582fs +/− CMTs ( fig. S2H ), we conclude that the contractile deficits observed in mutant CMTs are not due to nonmyocyte factors. In addition, the comparable force deficits observed in CMTs with both A-band TTNtvs and the Z/I junction missense mutation demonstrate that W976R +/− is a pathogenic TTN missense mutation.
To ensure that the observed functional abnormalities did not reflect background genetic differences in patient-derived iPS-CMs, we also introduced TTNtvs into an independent, isogenic iPS cell using scarless, CRISPR (clustered regularly interspaced short palindromic repeats)/ CAS9 technology (5) to target the I-or A-band exons ( Fig. 1A and table S1B ). Mutant isogenic iPS cell lines (labeled with "c" preceding genotype) were differentiated into iPS-CMs and incorporated into CMTs. cN22577fs +/− creates an A-band TTNtv in exon 322 (similar to patient-derived pP22582fs +/− ) (Fig. 1A) . cN22577fs +/− CMTs had significantly reduced contractile force (2.19 mN) compared with isogenic cWT-CMTs (Fig. 1E ) (P < 0.003), but not to the extent observed in pA22352fs +/− or pP22582fs +/− CMTs (0.767 and 1.001 mN, respectively; P < 0.02). Tissue stress was similarly reduced in TTNtv CMTs compared to WT CMTs ( fig. S2J ). These data confirm that A-band TTNtvs markedly reduced contractile function in both patient-derived and isogenic CMTs and raise the possibility that the genetic background can modify the functional severity of TTNtvs.
Premature protein truncation at any location within a molecule is generally assumed to result in loss of function and comparable deleterious consequences. However, I-band TTNtvs have been identified in healthy individuals and in the general population without DCM (2, 3). Two models have been proposed to explain this dichotomy: (i) Alternative splicing excludes I-band exons from most mature TTN transcripts and thereby reduces the functional consequences of I-band TTNtvs, whereas the inclusion of A-band exons with TTNtvs is deleterious. (ii) A-band TTNtv transcripts produce longer, stable mutant proteins with dominant negative effects on sarcomere biology. To distinguish these models, we compared the functional consequences of isogenic ) generated small but demonstrable force (0.472 mN), presumably due to 18% of TTN transcripts that excluded exon 66 and the TTNtv ( fig. S3A ). On the basis of these functional and RNA-seq data, we suggest that alternative exon splicing is the predominant mechanism for reduced penetrance of Iband TTNtvs.
As TTN is responsible for sensing and responding to myocardial stresses (13), we posited that TTNtv mutants would exhibit aberrant stress responses. To model low and high mechanical load, we assessed contractile performance of pWT and pP22582fs +/− CMTs grown on flexible (0.2 mN/mm) and rigid (0.45 mN/mm) cantilevers (Fig.  1F ). pP22582fs +/− CMTs produced less force than pWT CMTs at low load. At higher load, pWT CMTs produced a twofold increase in force, greater than four times that produced by pP22582fs +/− CMTs. In response to isoproterenol treatment to mimic b-adrenergic stimulation, force and beating rate were increased in pWT CMTs, but pP22582fs
CMTs had markedly blunted responses (Fig. 1, G and H). Together, these data demonstrate that TTNtvs had both basal and stress-induced inotropic and chronotropic deficits that are expected to impair cardiac adaptation to increased mechanical load and b-adrenergic signaling.
We considered whether A-band TTNtvs affected the organization of the sarcomere, where TTN is localized, which could cause or contribute to functional defects. Using antibodies to TTN (9D10 recognizes the N-terminus of TTNtvs) ( Fig.  2A) and a-actinin (Fig. 2, B and C) , we identified well-formed parallel arrays of repeating sarcomeres in myofibrils from WT iPS-CMs. pP22582fs +/− iPS-CMs had fewer myofibrils and abnormal, irregular sarcomeres, a phenotype that was even more pronounced in homozygous cT33520fs −/− iPS-CMs (Fig. 2, A and D, and fig. S4A ). Sarcomere disorganization was observed regardless of whether the iPS-CMs were aligned on micropatterned lines (Fig. 2B ) or 3D CMTs (Fig. 2C) . In addition, sarcomere length was shorter in pP22582fs +/− CMs compared with pWT CMs (Fig.  2E) , indicating both a quantitative and qualitative defect in sarcomerogenesis. Analogous to these results, LV tissue from the patient with the P22582fs +/− mutation showed disorganized myofibrils compared with control tissue (Fig. 2, G  and H, and fig. S4B ).
To determine whether sarcomere deficits reflected insufficient TTN levels, we performed RNA-seq (14) and C). RNA-seq (table S1D) and Sanger sequencing of reverse transcriptase polymerase chain reaction products ( fig. S5 ) demonstrated equal amounts of mutant and WT transcripts. Consistent with RNA-seq data, protein gels of iPS-CM extracts showed expression of the larger fetal TTN isoforms, which include more I-band exons than the adult TTN isoforms (Fig.  2F) . We next sought to identify truncated TTN protein (Fig. 2F and fig. S6 , (benign variant)] TTNtv. Both iPS-CMs and adult LV contained N2BA (~3300 to 3700 kD) and N2B TTN isoforms (~3000 kD); however, iPS-CM lysates also contained the larger fetal N2BA isoforms (~3700 kD). In addition, a smaller fragment (~2500 kD) was present in pP22582fs +/− iPS-CM extracts, but not in pWT (Fig. 2F) , pA22353fs +/− , or pS6394fs +/− iPS-CMs ( fig. S6, B and C Coomassie Blue (for additional blots, see fig S6) . Sizes of TTN isoforms and fragments are as follows: N2BA fetal,~3700 kD; N2BA adult,~3300 kD; N2B, 3000kD; TTNtvs,~2500 kD; degraded TTN,~1800 to 2200 kD. Obscurin size is 700 kD. Western blots (WB) were probed with N-terminal TTN antibody (T12 in fig. S6 ). TTNtv protein (~2500 kD) was detected in pP22582fs +/− iPS-CMs. (MAPKs) [MAPK kinase kinase (MEK) and extracellular signal-regulated kinase (ERK)]. Quantification of transcripts, proteins, and phosphorylation levels confirmed that TTNtv iPS-CMs exhibited significant attenuation (all P < 0.01) in the levels or phosphorylation of TGFb, VEGF, MAPKs, and AKT (Fig. 3, D to H) but not HGF, EGF, or FGF2 ( fig. S3E ). To determine whether these signaling deficits contributed to force deficits, we pretreated pP22582fs +/− and pW976R +/− iPS-CMs with VEGF (50 ng/ml) or TGF-b (0.5 ng/ml) for 4 days before studying CMTs. In contrast to the failed augmentation in response to mechanical load (Fig. 1F) or b-adrenergic stimulation (Fig. 1G) , supplementation with VEGF, but not TGF-b (fig. S3F) , improved force production in pP22582fs +/− and pW976R +/− CMTs (Fig. 3I) . Coupled with engineered biomimetic culture systems, the use of patient-derived or gene-editing technologies to produce iPS-CMs provides robust functional genomic insights. Our studies of iPS-CM with different TTN mutations revealed that some missense variants like TTNtvs are pathogenic, whereas comparisons of contractile function in patient-derived and isogenic CMTs implied a role for genetic modifiers in clinical manifestations of TTNtvs. We found that both Iand A-band TTNtvs can cause substantial contractile deficits but that alternative exon splicing ( fig. S3, A and B) mitigates the pathogenicity of I-band TTNtvs. Additional factors-such as iPS-CMs not fully recapitulating the cell biology of adult cardiomyocytes and CMT tissues lacking in vivo compensatory responses-may also account for different degrees of contractile deficits in iPS-CMTs and human hearts with TTNtvs. Surprisingly, some TTNtvs produced stable truncated protein, but this mutant peptide failed to assemble with other contractile proteins into well-organized functional sarcomeres. The resultant sarcomere insufficiency ( fig. S7) A challenge of synthetic biology is the creation of cooperative microbial systems that exhibit population-level behaviors. Such systems use cellular signaling mechanisms to regulate gene expression across multiple cell types. We describe the construction of a synthetic microbial consortium consisting of two distinct cell types-an "activator" strain and a "repressor" strain. These strains produced two orthogonal cell-signaling molecules that regulate gene expression within a synthetic circuit spanning both strains. The two strains generated emergent, population-level oscillations only when cultured together. Certain network topologies of the two-strain circuit were better at maintaining robust oscillations than others. The ability to program population-level dynamics through the genetic engineering of multiple cooperative strains points the way toward engineering complex synthetic tissues and organs with multiple cell types.
M ost synthetic gene circuits have been constructed to operate within single, isogenic cellular populations (1-4). However, synthetic microbial consortia could provide a means of engineering population-level phenotypes that are difficult to obtain with single strains (5) . Indeed, several synthetic systems have been constructed to exhibit population-level phenotypes (6-9), including synthetic predator-prey systems (10), multicellular computers (11), and spatio-temporal pattern generators (12, 13) . We constructed two genetically distinct populations of Escherichia coli to create a bacterial consortium that exhibits robust, synchronized transcriptional oscillations that are absent if either strain is grown in isolation. Specifically, we used two different bacterial quorum-sensing systems to construct an "activator" strain and a "repressor" strain that respectively increase and decrease gene expression in both strains. When cultured together in a microfluidic device, the two strains form coupled positive and negative feedback loops at the population level, akin to the circuit topology (i.e., how regulatory components within a circuit regulate each other) of a synthetic dual-feedback oscillator that operates within a single strain (14, 15) . We used a combination of mathematical modeling and targeted genetic perturbations to better understand the roles of circuit topology and regulatory promoter strengths in generating and maintaining oscillations. The dual-feedback topology was robust to changes in promoter strengths and fluctuations in the population ratio of the two strains.
The two synthetic strains in our system were constructed to enzymatically produce and transcriptionally respond to intercellular signaling molecules (Fig. 1A) . The activator strain produces C4-homoserine lactone (C4-HSL) (16), a signaling molecule that increases transcription of target genes within the synthetic circuits of both strains. The repressor strain produces 3-OHC14-HSL (17), which decreases transcription in both strains through a synthetic transcriptional inverter (18, 19) mediated by the repressor LacI. These two signaling mechanisms jointly create coupled positive and negative feedback loops at the population level when the two strains are grown together (Fig. 1B) . Additionally, each strain, when active, produces the enzyme AiiA, which degrades both signaling molecules, resulting in another layer of negative feedback.
To observe the dynamics of the synthetic consortium, we used a custom-designed microfluidic device in conjunction with time-lapse fluorescence microscopy to observe the two strains as they grew together in a small chamber in which the diffusion time of the HSLs was small (see supplementary materials) (20) . Each strain contained a gene encoding a spectrally distinct fluorescent reporter (cfp, cyan fluorescent protein, in the activator; yfp, yellow fluorescent protein, in the repressor), driven by promoters that respond to both positive and negative signals in the network (Fig. 1A) . After an initial transient time, synchronous, in-phase oscillations emerged in the fluorescent reporters of both strains (Fig. 1, C and D) . Neither strain oscillated when cultured in isolation ( fig. S1 ). Oscillations had a period of~2 hours and persisted throughout the experiments (usually more than 14 hours).
The circuit topology of our synthetic consortium consisted of linked positive and negative feedback loops, similar to the topologies of many naturally occurring biological oscillators (21, 22).
